Who invested in Orbis Medicines?
Orbis Medicines's investors include New Enterprise Associates, Novo Holdings, Cormorant Asset Management, Eli Lilly and Forbion Capital Partners, and 3 more on record.

Denmark · Venture startup
Funding summaryUpdated 26 Oct 2026
$187Mraised across 2 rounds since 2025, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
From Orbis Medicines's own website: 6 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Orbis Medicines's investors include New Enterprise Associates, Novo Holdings, Cormorant Asset Management, Eli Lilly and Forbion Capital Partners, and 3 more on record.
Orbis Medicines has raised $187M across 2 rounds since 2025.
Orbis Medicines's most recent round was a Venture of $94M in Sept 2026.
Its most recent round, $94M in Sept 2026, is also its largest on record.
Orbis Medicines's first round on record, in Jan 2025, was backed by NEA - New Enterprise Associates, New Enterprise Associates and Novo Holdings and 5 others.
Orbis Medicines's latest named round is a Venture, in Sept 2026.
Orbis Medicines is based in Denmark.
NEA - New Enterprise Associates led the Series A in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.